X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (13210) 13210
Book Review (2712) 2712
Publication (1240) 1240
Book Chapter (131) 131
Conference Proceeding (70) 70
Dissertation (27) 27
Newsletter (16) 16
Magazine Article (8) 8
Book / eBook (5) 5
Government Document (5) 5
Newspaper Article (5) 5
Reference (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10501) 10501
humans (8918) 8918
oncology (5727) 5727
tumor-infiltrating lymphocytes (5678) 5678
female (4868) 4868
lymphocytes, tumor-infiltrating - immunology (4051) 4051
immunotherapy (3886) 3886
cancer (3631) 3631
animals (3411) 3411
immunology (3407) 3407
male (3146) 3146
middle aged (2983) 2983
aged (2526) 2526
mice (2290) 2290
lymphocytes (2256) 2256
adult (2223) 2223
prognosis (2211) 2211
expression (2102) 2102
tumors (1883) 1883
melanoma (1767) 1767
infiltrating lymphocytes (1676) 1676
t cells (1574) 1574
immunohistochemistry (1550) 1550
lymphocytes, tumor-infiltrating - pathology (1469) 1469
survival (1443) 1443
t-cells (1368) 1368
t-lymphocytes - immunology (1339) 1339
dendritic cells (1305) 1305
lymphocytes, tumor-infiltrating - metabolism (1247) 1247
medicine, research & experimental (1242) 1242
cd8-positive t-lymphocytes - immunology (1201) 1201
carcinoma (1193) 1193
melanoma - immunology (1133) 1133
metastatic melanoma (1120) 1120
neoplasms - immunology (1110) 1110
breast cancer (1056) 1056
t-lymphocytes, cytotoxic - immunology (1055) 1055
chemotherapy (1047) 1047
care and treatment (1036) 1036
aged, 80 and over (1019) 1019
research (1018) 1018
tumor cells, cultured (1002) 1002
abridged index medicus (1000) 1000
pathology (966) 966
regulatory t-cells (965) 965
analysis (959) 959
metastasis (957) 957
antigens, neoplasm - immunology (941) 941
flow cytometry (875) 875
antigens (873) 873
cell biology (859) 859
neoplasm staging (859) 859
cell line, tumor (857) 857
mice, inbred c57bl (850) 850
cells (843) 843
in-vivo (834) 834
neoplasms - therapy (822) 822
interleukin-2 (819) 819
article (799) 799
apoptosis (791) 791
lymphocytes t (782) 782
gene expression (754) 754
therapy (731) 731
surgery (717) 717
adoptive immunotherapy (711) 711
immunotherapy - methods (695) 695
cytotoxicity, immunologic (685) 685
tumor microenvironment (668) 668
health aspects (661) 661
immunotherapy, adoptive (654) 654
antigen (631) 631
treatment outcome (631) 631
t-lymphocytes, regulatory - immunology (630) 630
melanoma - therapy (627) 627
immunity (622) 622
lymphocyte activation (622) 622
breast-cancer (613) 613
cytokines (608) 608
peripheral-blood (608) 608
melanoma - pathology (603) 603
cd4-positive t-lymphocytes - immunology (601) 601
immune response (601) 601
medicine & public health (596) 596
t-lymphocyte subsets - immunology (594) 594
metastases (588) 588
activation (583) 583
inflammation (583) 583
medical prognosis (557) 557
identification (549) 549
phenotype (548) 548
patients (539) 539
cytotoxicity (536) 536
breast neoplasms - immunology (533) 533
colorectal cancer (532) 532
development and progression (530) 530
tumor infiltrating lymphocytes (525) 525
breast neoplasms - pathology (512) 512
lymphocytes, tumor-infiltrating - drug effects (512) 512
mice, inbred balb c (510) 510
cd8 antigen (500) 500
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12923) 12923
French (110) 110
Chinese (107) 107
Japanese (74) 74
German (62) 62
Spanish (23) 23
Russian (18) 18
Czech (12) 12
Polish (12) 12
Italian (10) 10
Hungarian (6) 6
Korean (6) 6
Serbian (2) 2
Arabic (1) 1
Danish (1) 1
Finnish (1) 1
Georgian (1) 1
Portuguese (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2014, Volume 63, Issue 4, pp. 395 - 406
The programmed death-1 (PD-1) molecule is mainly expressed on functionally “exhausted” CD8+ T cells, dampening the host antitumor immune response. We evaluated... 
Immunology | Medicine & Public Health | Oncology | Cancer Research | Breast cancer | Immune evasion | Regulatory T cells | Cancer immunotherapy | PD-1 | APOPTOSIS | PROGNOSIS | TUMOR | RISK | ANTIBODY | IMMUNOLOGY | CHEMOTHERAPY | HEPATOCELLULAR-CARCINOMA | ONCOLOGY | IMMUNOTHERAPY | CD8(+) T-LYMPHOCYTES | B7-H1 | Carcinoma, Lobular - pathology | Follow-Up Studies | Breast Neoplasms - immunology | Humans | Middle Aged | Programmed Cell Death 1 Receptor - analysis | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | Antigens, Differentiation, T-Lymphocyte - analysis | Aged, 80 and over | Carcinoma, Ductal, Breast - pathology | Lymphocytes, Tumor-Infiltrating - chemistry | T-Lymphocytes, Regulatory - chemistry | Carcinoma, Lobular - immunology | CD8-Positive T-Lymphocytes - chemistry | Combined Modality Therapy | Carcinoma, Lobular - radiotherapy | T-Lymphocyte Subsets - pathology | Carcinoma, Ductal, Breast - radiotherapy | Forkhead Transcription Factors - analysis | Survival Analysis | CD8-Positive T-Lymphocytes - immunology | Lymphocytes, Tumor-Infiltrating - immunology | T-Lymphocyte Subsets - immunology | Breast Neoplasms - surgery | CD8-Positive T-Lymphocytes - pathology | Prognosis | Carcinoma, Ductal, Breast - immunology | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | T-Lymphocytes, Cytotoxic - pathology | T-Lymphocyte Subsets - chemistry | Mastectomy | Adult | Female | Radiotherapy, Adjuvant | T-Lymphocytes, Cytotoxic - immunology | Carcinoma, Ductal, Breast - surgery | Carcinoma, Lobular - surgery | Kaplan-Meier Estimate | Disease-Free Survival | Breast Neoplasms - radiotherapy | T-Lymphocytes, Cytotoxic - chemistry | Apoptosis - immunology | Lymphocytes, Tumor-Infiltrating - pathology | Breast Neoplasms - pathology | Lymphocyte Count | Breast Neoplasms - mortality | Aged | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 02/2011, Volume 71, Issue 4, pp. 1263 - 1271
The tumor microenvironment includes a complex network of immune T-cell subpopulations. In this study, we systematically analyzed the balance between cytotoxic... 
BREAST-CANCER | SURVIVAL | LUNG-CANCER | FOXP3 EXPRESSION | RECRUITMENT | ONCOLOGY | GASTRIC-CANCER | EOSINOPHILS | MACROPHAGES | CARCINOMA | LYMPHOCYTES | Th1 Cells - pathology | Th1 Cells - physiology | Prognosis | Th2 Cells - physiology | Tissue Array Analysis | Colorectal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | Carcinoma - mortality | Gene Expression Profiling | Th2 Cells - immunology | Th1 Cells - immunology | Colorectal Neoplasms - diagnosis | Lymphocytes, Tumor-Infiltrating - physiology | T-Lymphocytes, Cytotoxic - pathology | Th1 Cells - metabolism | Th17 Cells - metabolism | Forkhead Transcription Factors - metabolism | Microarray Analysis | T-Lymphocytes, Helper-Inducer - immunology | Lymphocytes, Tumor-Infiltrating - metabolism | T-Lymphocytes, Helper-Inducer - pathology | Interleukin-4 - genetics | Th2 Cells - pathology | Th17 Cells - pathology | Colorectal Neoplasms - mortality | T-Lymphocytes, Cytotoxic - immunology | Th17 Cells - physiology | T-Lymphocytes, Helper-Inducer - metabolism | Carcinoma - immunology | Interleukin-4 - metabolism | Carcinoma - diagnosis | Forkhead Transcription Factors - genetics | Th2 Cells - metabolism | T-Lymphocytes, Cytotoxic - physiology | T-Lymphocytes, Helper-Inducer - physiology | Colorectal Neoplasms - immunology | Lymphocytes, Tumor-Infiltrating - pathology | T-Lymphocytes, Cytotoxic - metabolism | Survival Analysis | Th17 Cells - immunology | Carcinoma - genetics | Cohort Studies | Lymphocytes, Tumor-Infiltrating - immunology | Index Medicus
Journal Article
European Journal of Immunology, ISSN 0014-2980, 07/2016, Volume 46, Issue 7, pp. 1770 - 1782
We previously demonstrated an accumulation of tumor‐reactive CD4 + CD8 + double positive (DP) T cells within melanoma‐infiltrating lymphocytes, supporting... 
CD4 | double‐positive T lymphocyte | CD8 | TIL | Melanoma | IL‐9R | IL‐9 | IL-9R | double-positive T lymphocyte | IL-9 | TH9 CELLS | CD8(+) | INDUCED APOPTOSIS | INTERLEUKIN-9 | RECEPTOR | PERIPHERAL-BLOOD | IMMUNOLOGY | CYTOKINE EXPRESSION | IN-VIVO | CD4(+) CD8(+) double-positive T lymphocyte | GROWTH-FACTOR | LYMPHOCYTES | T-Lymphocyte Subsets - immunology | Apoptosis - drug effects | Humans | CD4-Positive T-Lymphocytes - immunology | Lymphocyte Activation - immunology | Interleukin-9 - pharmacology | Melanoma - genetics | T-Lymphocyte Subsets - drug effects | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Cytotoxicity, Immunologic - drug effects | Melanoma - metabolism | Receptors, Interleukin-9 - metabolism | Gene Expression | Cytokines - metabolism | CD4-Positive T-Lymphocytes - metabolism | Cells, Cultured | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Cell Survival - immunology | Apoptosis - immunology | Receptors, Interleukin-9 - genetics | Lymphocyte Activation - drug effects | Melanoma - immunology | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - drug effects | CD8-Positive T-Lymphocytes - immunology | Interleukin-9 - immunology | CD4-Positive T-Lymphocytes - drug effects | Lymphocytes, Tumor-Infiltrating - immunology | Parrots | T cells | Tumors | Index Medicus | Life Sciences | Cancer
Journal Article
Cancer Research, ISSN 0008-5472, 06/2013, Volume 73, Issue 12, pp. 3591 - 3603
Tumor progression is facilitated by regulatory T cells (Treg) and restricted by effector T cells. In this study, we document parallel regulation of CD8(+) T... 
DISTINCT MECHANISMS | ONCOLOGY | PROGRAMMED DEATH-1 | IMMUNE ESCAPE | MYELOID-LEUKEMIA | SYNGENEIC MOUSE MODEL | REGULATORY T | GROWTH-FACTOR | CHRONIC VIRAL-INFECTION | ANTITUMOR-ACTIVITY | HUMAN OVARIAN-CANCER | T-Lymphocytes, Regulatory - metabolism | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antibodies, Blocking - pharmacology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Neoplasms, Experimental - pathology | Flow Cytometry | T-Lymphocytes - metabolism | Neoplasms, Experimental - immunology | CD8-Positive T-Lymphocytes - metabolism | Female | Lymphocytes, Tumor-Infiltrating - metabolism | Cytokines - immunology | Cytokines - metabolism | Cancer Vaccines - administration & dosage | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Neoplasms, Experimental - therapy | CTLA-4 Antigen - metabolism | Lymphocytes, Tumor-Infiltrating - transplantation | Programmed Cell Death 1 Receptor - metabolism | Combined Modality Therapy | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Cancer Vaccines - immunology | B7-H1 Antigen - metabolism | Animals | Antibodies, Blocking - immunology | T-Lymphocytes - immunology | Mice | Mice, Inbred BALB C | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Lymphocytes, Tumor-Infiltrating - immunology | Tumor Burden - immunology | Index Medicus
Journal Article
Journal of Immunology, ISSN 0022-1767, 04/2015, Volume 194, Issue 7, pp. 3475 - 3486
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 06/2011, Volume 108, Issue 26, pp. 10656 - 10661
Journal Article
Pancreas, ISSN 0885-3177, 01/2004, Volume 28, Issue 1, pp. e26 - 31
Journal Article
British Journal of Cancer, ISSN 0007-0920, 04/2015, Volume 112, Issue 9, pp. 1501 - 1509
Journal Article
Proceedings of the National Academy of Sciences, ISSN 0027-8424, 04/2012, Volume 109, Issue 16, pp. 6187 - 6192
IL-15 has potential as an immunotherapeutic agent for cancer treatment because of its ability to effectively stimulate CD8 T cell, natural killer T cell, and... 
LUNG-CANCER | RESPONSES | IMMUNITY | GROWTH-FACTOR-BETA | TOLERANCE | MULTIDISCIPLINARY SCIENCES | CTLA-4 | PROLIFERATION | PD-1 | IL-10 | CUTTING EDGE | T-Lymphocyte Subsets - immunology | T-Lymphocytes, Regulatory - metabolism | Humans | Male | Interferon-gamma - metabolism | Prostatic Neoplasms - immunology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Flow Cytometry | T-Lymphocyte Subsets - drug effects | Antibodies - immunology | CD8-Positive T-Lymphocytes - metabolism | Lymphocytes, Tumor-Infiltrating - metabolism | Cytotoxicity, Immunologic - drug effects | Prostatic Neoplasms - drug therapy | Disease Models, Animal | Amino Acid Sequence | Prostatic Neoplasms - pathology | Mice, Inbred C57BL | CD4-Positive T-Lymphocytes - metabolism | Kaplan-Meier Estimate | CTLA-4 Antigen - metabolism | Treatment Outcome | Interleukin-5 - administration & dosage | Lymphocytes, Tumor-Infiltrating - drug effects | CTLA-4 Antigen - immunology | B7-H1 Antigen - immunology | Antibodies - administration & dosage | B7-H1 Antigen - metabolism | T-Lymphocytes, Regulatory - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocyte Subsets - metabolism | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Cell Line, Tumor | Mice | CD8-Positive T-Lymphocytes - immunology | Cytotoxicity, Immunologic - immunology | CD4-Positive T-Lymphocytes - drug effects | Lymphocytes, Tumor-Infiltrating - immunology | Tumor Burden - immunology | Interleukins | Immunotherapy | Physiological aspects | Development and progression | T cells | Health aspects | Prostate cancer | Clinical trials | T cell receptors | Cytokines | Rodents | Tumors | Index Medicus | Adenocarcinoma | Animal models | Cell survival | CD8 antigen | Immunoregulation | Antibodies | Cytotoxicity | Lymphocytes T | Interleukin 15 | CD4 antigen | CTLA-4 protein | PD-L1 protein | gamma -Interferon | Antitumor activity | CD25 antigen | Natural killer cells | Prostate | Biological Sciences
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2011, Volume 121, Issue 6, pp. 2350 - 2360
Journal Article